메뉴 건너뛰기




Volumn 2014, Issue , 2014, Pages

The use of humoral responses as a marker of CMV burden in HIV patients on ART requires consideration of T-cell recovery and persistent B-cell activation

Author keywords

[No Author keywords available]

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIBODY; CD14 ANTIGEN; IMMUNOGLOBULIN G; TUMOR NECROSIS FACTOR RECEPTOR 1; B CELL ACTIVATING FACTOR; BIOLOGICAL MARKER; TNFSF13B PROTEIN, HUMAN; VIRUS ANTIBODY;

EID: 84916224374     PISSN: 02780240     EISSN: 18758630     Source Type: Journal    
DOI: 10.1155/2014/947432     Document Type: Article
Times cited : (15)

References (26)
  • 1
    • 0041941609 scopus 로고    scopus 로고
    • Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360)
    • 2-s2.0-0041941609
    • Erice A., Tierney C., Hirsch M., Cytomegalovirus (CMV) and human immunodeficiency virus (HIV) burden, CMV end-organ disease, and survival in subjects with advanced HIV infection (AIDS Clinical Trials Group Protocol 360). Clinical Infectious Diseases 2003 37 4 567 578 10.1086/375843 2-s2.0-0041941609
    • (2003) Clinical Infectious Diseases , vol.37 , Issue.4 , pp. 567-578
    • Erice, A.1    Tierney, C.2    Hirsch, M.3
  • 2
    • 0032518617 scopus 로고    scopus 로고
    • Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients
    • 2-s2.0-0032518617
    • Spector S. A., Wong R., Hsia K., Pilcher M., Stempien M. J., Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. The Journal of Clinical Investigation 1998 101 2 497 502 10.1172/JCI1101 2-s2.0-0032518617
    • (1998) The Journal of Clinical Investigation , vol.101 , Issue.2 , pp. 497-502
    • Spector, S.A.1    Wong, R.2    Hsia, K.3    Pilcher, M.4    Stempien, M.J.5
  • 3
    • 68449093190 scopus 로고    scopus 로고
    • CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: A 2-year follow-up study in the Netherlands
    • 2-s2.0-68449093190
    • Goossens V. J., Wolffs P. F., van Loo I. H., Bruggeman C. A., Verbon A., CMV DNA levels and CMV gB subtypes in ART-naive HAART-treated patients: a 2-year follow-up study in the Netherlands. AIDS 2009 23 11 1425 1429 10.1097/QAD.0b013e32832c165c 2-s2.0-68449093190
    • (2009) AIDS , vol.23 , Issue.11 , pp. 1425-1429
    • Goossens, V.J.1    Wolffs, P.F.2    Van Loo, I.H.3    Bruggeman, C.A.4    Verbon, A.5
  • 4
    • 0032882094 scopus 로고    scopus 로고
    • Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease
    • 2-s2.0-0032882094
    • Verbraak F. D., Boom R., Wertheim-van Dillen P. M. E., van den Horn G. J., Kijlstra A., de Smet M. D., Influence of highly active antiretroviral therapy on the development of CMV disease in HIV positive patients at high risk for CMV disease. British Journal of Ophthalmology 1999 83 10 1186 1189 10.1136/bjo.83.10.1186 2-s2.0-0032882094
    • (1999) British Journal of Ophthalmology , vol.83 , Issue.10 , pp. 1186-1189
    • Verbraak, F.D.1    Boom, R.2    Wertheim-Van Dillen, P.M.E.3    Van Den Horn, G.J.4    Kijlstra, A.5    De Smet, M.D.6
  • 5
    • 79551614790 scopus 로고    scopus 로고
    • HIV infection, inflammation, immunosenescence, and aging
    • 2-s2.0-79551614790
    • Deeks S. G., HIV infection, inflammation, immunosenescence, and aging. Annual Review of Medicine 2011 62 141 155 10.1146/annurev-med-042909-093756 2-s2.0-79551614790
    • (2011) Annual Review of Medicine , vol.62 , pp. 141-155
    • Deeks, S.G.1
  • 8
    • 77955874092 scopus 로고    scopus 로고
    • Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up
    • 2-s2.0-77955874092
    • Roberts E. T., Haan M. N., Dowd J. B., Aiello A. E., Cytomegalovirus antibody levels, inflammation, and mortality among elderly Latinos over 9 years of follow-up. American Journal of Epidemiology 2010 172 4 363 371 10.1093/aje/kwq177 2-s2.0-77955874092
    • (2010) American Journal of Epidemiology , vol.172 , Issue.4 , pp. 363-371
    • Roberts, E.T.1    Haan, M.N.2    Dowd, J.B.3    Aiello, A.E.4
  • 9
    • 0242317690 scopus 로고    scopus 로고
    • Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination - An impact of immunosenescence
    • 2-s2.0-0242317690
    • Trzonkowski P., Mys̈liwska J., Szmit E., Association between cytomegalovirus infection, enhanced proinflammatory response and low level of anti-hemagglutinins during the anti-influenza vaccination-an impact of immunosenescence. Vaccine 2003 21 25-26 3826 3836 10.1016/S0264-410X(03)00309-8 2-s2.0-0242317690
    • (2003) Vaccine , vol.21 , Issue.25-26 , pp. 3826-3836
    • Trzonkowski, P.1    Mys̈liwska, J.2    Szmit, E.3
  • 10
    • 0036932579 scopus 로고    scopus 로고
    • Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy
    • 2-s2.0-0036932579
    • Almeida C. A., Price P., French M. A., Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy. AIDS Research and Human Retroviruses 2002 18 18 1351 1355 10.1089/088922202320935429 2-s2.0-0036932579
    • (2002) AIDS Research and Human Retroviruses , vol.18 , Issue.18 , pp. 1351-1355
    • Almeida, C.A.1    Price, P.2    French, M.A.3
  • 11
    • 84877329810 scopus 로고    scopus 로고
    • Characterization of plasmablasts in the blood of HIV-infected viremic individuals: Evidence for nonspecific immune activation
    • 2-s2.0-84877329810
    • Buckner C. M., Moir S., Ho J., Characterization of plasmablasts in the blood of HIV-infected viremic individuals: evidence for nonspecific immune activation. Journal of Virology 2013 87 10 5800 5811 10.1128/JVI.00094-13 2-s2.0-84877329810
    • (2013) Journal of Virology , vol.87 , Issue.10 , pp. 5800-5811
    • Buckner, C.M.1    Moir, S.2    Ho, J.3
  • 12
    • 63149142646 scopus 로고    scopus 로고
    • B cells in HIV infection and disease
    • Moir S., Fauci A. S., B cells in HIV infection and disease. Nature Reviews Immunology 2009 9 4 235 245
    • (2009) Nature Reviews Immunology , vol.9 , Issue.4 , pp. 235-245
    • Moir, S.1    Fauci, A.S.2
  • 15
    • 4544264445 scopus 로고    scopus 로고
    • Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily
    • Moir S., Malaspina A., Pickeral O. K., Decreased survival of B cells of HIV-viremic patients mediated by altered expression of receptors of the TNF superfamily. The Journal of Experimental Medicine 2004 200 7 587 599 10.1084/jem.20032236
    • (2004) The Journal of Experimental Medicine , vol.200 , Issue.7 , pp. 587-599
    • Moir, S.1    Malaspina, A.2    Pickeral, O.K.3
  • 16
    • 0030332273 scopus 로고    scopus 로고
    • B-lymphocytes and autoantibody profiles in HIV disease
    • Ng V. L., B-lymphocytes and autoantibody profiles in HIV disease. Clinical Reviews in Allergy & Immunology 1996 14 4 367 384
    • (1996) Clinical Reviews in Allergy & Immunology , vol.14 , Issue.4 , pp. 367-384
    • Ng, V.L.1
  • 18
    • 79551583111 scopus 로고    scopus 로고
    • Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation
    • 2-s2.0-79551583111
    • Regidor D. L., Detels R., Breen E. C., Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation. AIDS 2011 25 3 303 314 10.1097/QAD.0b013e32834273ad 2-s2.0-79551583111
    • (2011) AIDS , vol.25 , Issue.3 , pp. 303-314
    • Regidor, D.L.1    Detels, R.2    Breen, E.C.3
  • 20
    • 67649853099 scopus 로고    scopus 로고
    • Cracking the BAFF code
    • 2-s2.0-67649853099
    • MacKay F., Schneider P., Cracking the BAFF code. Nature Reviews Immunology 2009 9 7 491 502 10.1038/nri2572 2-s2.0-67649853099
    • (2009) Nature Reviews Immunology , vol.9 , Issue.7 , pp. 491-502
    • Mackay, F.1    Schneider, P.2
  • 21
    • 84895770151 scopus 로고    scopus 로고
    • Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk
    • Strautins K., Tschochner M., James I., Combining HLA-DR risk alleles and anti-Epstein-Barr virus antibody profiles to stratify multiple sclerosis risk. Multiple Sclerosis 2014 20 3 286 294
    • (2014) Multiple Sclerosis , vol.20 , Issue.3 , pp. 286-294
    • Strautins, K.1    Tschochner, M.2    James, I.3
  • 22
    • 0031016170 scopus 로고    scopus 로고
    • The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies
    • 2-s2.0-0031016170
    • Schoppel K., Kropff B., Schmidt C., Vornhagen R., Mach M., The humoral immune response against human cytomegalovirus is characterized by a delayed synthesis of glycoprotein-specific antibodies. The Journal of Infectious Diseases 1997 175 3 533 544 10.1093/infdis/175.3.533 2-s2.0-0031016170
    • (1997) The Journal of Infectious Diseases , vol.175 , Issue.3 , pp. 533-544
    • Schoppel, K.1    Kropff, B.2    Schmidt, C.3    Vornhagen, R.4    Mach, M.5
  • 23
    • 33745009339 scopus 로고    scopus 로고
    • Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART
    • 2-s2.0-33745009339
    • Burgess K., Price P., James I. R., Stone S. F., Keane N. M., Lim A. Y. F., Warmington J. R., French M. A., Interferon-gamma responses to Candida recover slowly or remain low in immunodeficient HIV patients responding to ART. Journal of Clinical Immunology 2006 26 2 160 167 10.1007/s10875-006-9008-4 2-s2.0-33745009339
    • (2006) Journal of Clinical Immunology , vol.26 , Issue.2 , pp. 160-167
    • Burgess, K.1    Price, P.2    James, I.R.3    Stone, S.F.4    Keane, N.M.5    Lim, A.Y.F.6    Warmington, J.R.7    French, M.A.8
  • 24
    • 0035575871 scopus 로고    scopus 로고
    • Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART
    • 2-s2.0-0035575871
    • Gerna G., Piccinini G., Genini E., Declining levels of rescued lymphoproliferative response to human cytomegalovirus (HCMV) in AIDS patients with or without HCMV disease following long-term HAART. Journal of Acquired Immune Deficiency Syndromes 2001 28 4 320 331 10.1097/00126334-200112010-00003 2-s2.0-0035575871
    • (2001) Journal of Acquired Immune Deficiency Syndromes , vol.28 , Issue.4 , pp. 320-331
    • Gerna, G.1    Piccinini, G.2    Genini, E.3
  • 25
    • 9244230035 scopus 로고    scopus 로고
    • Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy
    • 2-s2.0-9244230035
    • Keane N. M., Price P., Lee S., Almeida C. A., Stone S. F., James I., French M. A., Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy. HIV Medicine 2004 5 6 407 414 10.1111/j.1468-1293.2004.00245.x 2-s2.0-9244230035
    • (2004) HIV Medicine , vol.5 , Issue.6 , pp. 407-414
    • Keane, N.M.1    Price, P.2    Lee, S.3    Almeida, C.A.4    Stone, S.F.5    James, I.6    French, M.A.7
  • 26
    • 84906748287 scopus 로고    scopus 로고
    • Immune resilience in HIV-infected individuals seronegative for cytomegalovirus
    • Barrett L., Stapleton S. N., Fudge N. J., Grant M. D., Immune resilience in HIV-infected individuals seronegative for cytomegalovirus. AIDS 2014 28 14 2045 2049 10.1097/QAD.0000000000000405
    • (2014) AIDS , vol.28 , Issue.14 , pp. 2045-2049
    • Barrett, L.1    Stapleton, S.N.2    Fudge, N.J.3    Grant, M.D.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.